TY - JOUR
T1 - A disease mutation reveals a role for NaV1.9 in acute itch
AU - Salvatierra, Juan
AU - Diaz-Bustamante, Marcelo
AU - Meixiong, James
AU - Tierney, Elaine
AU - Dong, Xinzhong
AU - Bosmans, Frank
N1 - Funding Information:
This work was supported by a Department of Defense National Defense Science and Engineering Graduate Fellowship (to JS), a Blaustein Pain Research grant, a Johns Hopkins Catalyst Award, and a Johns Hopkins Bridge Funding Award to FB; the Hugo W.
Funding Information:
Moser Research Institute at Kennedy Krieger Inc. (to ET); a T32 GM007445 training grant; and NIH grants R01DE022750 and R01NS054791 to XD. XD is an Investigator of the Howard Hughes Medical Institute. We thank Peilin Shen for expert help with managing the mouse colonies, C. Hawkins and the staff of the Transgenic Mouse Core at Johns Hopkins University for assistance with transgenic mouse lines, Liang Han for the MrgprC11 antibody, and Roger Reeves, Michael Caterina, Matthias Ringkamp, and the members of the Bosmans laboratory for helpful discussions.
Publisher Copyright:
Copyright 2018, American Society for Clinical Investigation.
PY - 2018/12/3
Y1 - 2018/12/3
N2 - Itch (pruritis) and pain represent two distinct sensory modalities; yet both have evolved to alert us to potentially harmful external stimuli. Compared with pain, our understanding of itch is still nascent. Here, we report a new clinical case of debilitating itch and altered pain perception resulting from the heterozygous de novo p.L811P gain-of-function mutation in NaV1.9, a voltage-gated sodium (NaV) channel subtype that relays sensory information from the periphery to the spine. To investigate the role of NaV1.9 in itch, we developed a mouse line in which the channel is N-terminally tagged with a fluorescent protein, thereby enabling the reliable identification and biophysical characterization of NaV1.9-expressing neurons. We also assessed NaV1.9 involvement in itch by using a newly created NaV1.9–/– and NaV1.9L799P/WT mouse model. We found that NaV1.9 is expressed in a subset of nonmyelinated, nonpeptidergic small-diameter dorsal root ganglia (DRGs). In WT DRGs, but not those of NaV1.9–/– mice, pruritogens altered action potential parameters and NaV channel gating properties. Additionally, NaV1.9–/– mice exhibited a strong reduction in acute scratching behavior in response to pruritogens, whereas NaV1.9L799P/WT mice displayed increased spontaneous scratching. Altogether, our data suggest an important contribution of NaV1.9 to itch signaling.
AB - Itch (pruritis) and pain represent two distinct sensory modalities; yet both have evolved to alert us to potentially harmful external stimuli. Compared with pain, our understanding of itch is still nascent. Here, we report a new clinical case of debilitating itch and altered pain perception resulting from the heterozygous de novo p.L811P gain-of-function mutation in NaV1.9, a voltage-gated sodium (NaV) channel subtype that relays sensory information from the periphery to the spine. To investigate the role of NaV1.9 in itch, we developed a mouse line in which the channel is N-terminally tagged with a fluorescent protein, thereby enabling the reliable identification and biophysical characterization of NaV1.9-expressing neurons. We also assessed NaV1.9 involvement in itch by using a newly created NaV1.9–/– and NaV1.9L799P/WT mouse model. We found that NaV1.9 is expressed in a subset of nonmyelinated, nonpeptidergic small-diameter dorsal root ganglia (DRGs). In WT DRGs, but not those of NaV1.9–/– mice, pruritogens altered action potential parameters and NaV channel gating properties. Additionally, NaV1.9–/– mice exhibited a strong reduction in acute scratching behavior in response to pruritogens, whereas NaV1.9L799P/WT mice displayed increased spontaneous scratching. Altogether, our data suggest an important contribution of NaV1.9 to itch signaling.
UR - http://www.scopus.com/inward/record.url?scp=85058299352&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058299352&partnerID=8YFLogxK
U2 - 10.1172/JCI122481
DO - 10.1172/JCI122481
M3 - Article
C2 - 30395542
AN - SCOPUS:85058299352
SN - 0021-9738
VL - 128
SP - 5434
EP - 5447
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 12
ER -